A detailed history of Continuum Advisory, LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 350 shares of HCAT stock, worth $1,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350
Previous 332 5.42%
Holding current value
$1,288
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

BUY
$3.97 - $7.42 $71 - $133
18 Added 5.42%
350 $1,000
Q1 2024

May 10, 2024

BUY
$7.44 - $11.21 $2,470 - $3,721
332 New
332 $2,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $201M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.